ProfileGDS5678 / 1453060_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 14% 8% 8% 8% 8% 22% 8% 8% 8% 8% 8% 8% 8% 8% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3768814
GSM967853U87-EV human glioblastoma xenograft - Control 22.191368
GSM967854U87-EV human glioblastoma xenograft - Control 32.197318
GSM967855U87-EV human glioblastoma xenograft - Control 42.141398
GSM967856U87-EV human glioblastoma xenograft - Control 52.137088
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5920222
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.198138
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.176058
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.168988
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.188188
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.1778
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.166468
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.183088
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.185238